Ho CM, Hu RH, Lee PH. Perspective of antiviral therapeutics for hepatitis C after liver transplantation. World J Pharmacol 2014; 3(4): 193-198 [DOI: 10.5497/wjp.v3.i4.193]
Corresponding Author of This Article
Cheng-Maw Ho, MD, Department of Surgery, National Taiwan University Hospital, 7 Chun-Shan S Rd, Taipei 100, Taiwan. miningho@ntu.edu.tw
Research Domain of This Article
Transplantation
Article-Type of This Article
Therapeutics Advances
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/